Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05336656Completed

Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19

Role: lead

NCT04422808Completed

AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)

Role: lead

NCT03123107Phase 1Completed

Vitamin C in Cardiac Surgery Patients

Role: collaborator

NCT02047448Phase 2Completed

Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model

Role: lead

All 4 trials loaded